Non-oral continuous drug delivery based therapies and sleep dysfunction in Parkinson’s disease

Continuous drug delivery (CDD) has emerged as a feasible and pragmatic therapeutic option for dopamine replacement therapy in advanced Parkinson’s disease (PD). CDD aims to mimic the physiological tonic dopamine release from striatal dopaminergic neurons and thus reduces the severity and duration of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tall, P., Qamar, M. A., Batzu, L., Leta, V., Falup-Pecurariu, C., Ray Chaudhuri, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Neurology and Preclinical Neurological Studies - Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645607/
https://www.ncbi.nlm.nih.gov/pubmed/37126118
http://dx.doi.org/10.1007/s00702-023-02640-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645607/
https://www.ncbi.nlm.nih.gov/pubmed/37126118
http://dx.doi.org/10.1007/s00702-023-02640-7

Ejemplares similares